Center for Scientific Review; Notice of Closed Meetings, 62865-62866 [2022-22417]

Download as PDF Federal Register / Vol. 87, No. 199 / Monday, October 17, 2022 / Notices 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Eye Institute Special Emphasis Panel; NEI Mentored Clinician Scientist Applications (K08/K23). Date: November 10, 2022. Time: 9:30 a.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Eye Institute, 6700B Rockledge Dr., Bethesda, MD 20817 (Virtual Meeting). Contact Person: Jeanette M. Hosseini, Ph.D., Scientific Review Officer, 6700 B Rockledge Drive, Suite 3400, Bethesda, MD 20892, 301–451–2020, jeanetteh@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.867, Vision Research, National Institutes of Health, HHS) Dated: October 7, 2022. Victoria E. Townsend, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–22416 Filed 10–14–22; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings lotter on DSK11XQN23PROD with NOTICES1 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Pain Neurobiology. Date: November 8, 2022. Time: 11 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). VerDate Sep<11>2014 17:35 Oct 14, 2022 Jkt 259001 Contact Person: Roger Janz, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 402–8515, janzr2@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Cancer Immunology and Immunotherapy. Date: November 9–10, 2022. Time: 8:30 a.m. to 7 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn Capitol, 550 C Street SW, Washington, DC 20024. Contact Person: Ola Mae Zack Howard, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4192, MSC 7806, Bethesda, MD 20892, 301–451– 4467, howardz@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Biomedical Sensing, Measurement and Instrumentation. Date: November 9–10, 2022. Time: 9 a.m. to 7 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Steven Anthony Ripp, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–3010, steven.ripp@nih.gov. Name of Committee: Oncology 1—Basic Translational Integrated Review Group; Basic Mechanisms of Cancer Health Disparities Study Section. Date: November 9–10, 2022. Time: 9 a.m. to 8 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Sulagna Banerjee, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (612) 309–2479, sulagna.banerjee@ nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Endocrine and Metabolic Systems. Date: November 9, 2022. Time: 9 a.m. to 8 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Victoria Martinez Virador, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–4703, victoria.virador@ nih.gov. Name of Committee: Genes, Genomes, and Genetics Integrated Review Group; Therapeutic Approaches to Genetic Diseases Study Section. PO 00000 Frm 00084 Fmt 4703 Sfmt 4703 62865 Date: November 9–10, 2022. Time: 9:15 a.m. to 8 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Karobi Moitra, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480–6893, karobi.moitra@ nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Neurodevelopment, Synaptic Plasticity and Neurodegeneration—F03A. Date: November 9–10, 2022. Time: 9:30 a.m. to 7 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Robert C. Elliott, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5190, MSC 7846, Bethesda, MD 20892, 301–435– 3009, elliotro@csr.nih.gov. Name of Committee: Infectious Diseases and Immunology B Integrated Review Group; Host Interactions with Bacterial Pathogens Study Section. Date: November 9–10, 2022. Time: 9:30 a.m. to 8 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20876 (Virtual Meeting). Contact Person: Michelle Marie Arnold, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 451–7806, michelle.arnold@ nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Chemistry, Biochemistry and Biophysics B. Date: November 9–10, 2022. Time: 9:30 a.m. to 8 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Dennis Pantazatos, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–2381, dennis.pantazatos@ nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Hypersensitivity, Allergies and Mucosal Immunology (HAMI). Date: November 9–10, 2022. Time: 10 a.m. to 8 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). E:\FR\FM\17OCN1.SGM 17OCN1 62866 Federal Register / Vol. 87, No. 199 / Monday, October 17, 2022 / Notices lotter on DSK11XQN23PROD with NOTICES1 Contact Person: Kaushiki Mazumdar, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–1427, kaushiki.mazumdar@ nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Topics in Bacterial Pathogenesis. Date: November 9–10, 2022. Time: 10 a.m. to 7 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Diana Maria Ortiz-Garcia, Ph.D., Scientific Review Officer, The Center for Scientific Review, The National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301–594–5614, diana.ortizgarcia@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA–NS– 22–034: HEAL Initiative. Date: November 9, 2022. Time: 11 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Roger Janz, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 402–8515, janzr2@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Motivated Behavior, Alcohol and Neurotoxicology. Date: November 9, 2022. Time: 11 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Kirk Thompson, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5184, MSC 7844, Bethesda, MD 20892, 301–435– 1242, kgt@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: October 7, 2022. Victoria E. Townsend, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–22417 Filed 10–14–22; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Prospective Grant of Exclusive Patent License: Radiotherapeutics for Nasopharyngeal Cancer AGENCY: National Institutes of Health, HHS. ACTION: Notice. The National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to Molecular Targeting Technologies, Inc. (MTTI); a Delaware corporation, with its principle place of business in West Chester, Pennsylvania, to practice the inventions embodied in the issued patents and patent applications listed in the Supplementary Information section of this notice. SUMMARY: Only written comments and/or applications for a license which are received by the NHLBI Office of Technology Transfer and Development November 1, 2022 will be considered. DATES: Requests for copies of the patent applications, inquiries, and comments relating to the contemplated exclusive patent license should be directed to: Michael Davis, JD, Ph.D., Deputy Director, NHLBI OTTAD, 31 Center Drive Room 4A29, MSC2479, Bethesda, MD 20892–2479, phone number 301–451–9032, or michael.davis4@nih.gov. ADDRESSES: The following and all continuing U.S. and foreign patents/patent applications thereof are the intellectual properties to be licensed under the prospective agreement to MTTI: SUPPLEMENTARY INFORMATION: NIH Ref No. Patent No. or patent application No. Issue date Filing date Title E–150–2016–0–US–01 62/333,427 ................. .................................... May 9, 2019 .............. E–150–2016–0–PCT– 02. PCT/US2017/031696 .................................... May 9, 2017 .............. E–150–2016–0–CN– 03. 201780029003X ......... .................................... November 9, 2018 ..... E–150–2016–0–EP–04 3455206 ..................... November 4, 2020 ..... May 9, 2017 .............. E–150–2016–0–JP–05 2018–558662 ............. TBD (Allowed) ........... May 9, 2017 .............. E–150–2016–0–US–06 10,696,637 ................. June 30, 2020 ........... May 9, 2017 .............. E–150–2016–0–SG– 07. 11201809982R .......... November 8, 2021 ..... May 9, 2017 .............. E–150–2016–0–CH– 08. 3455206 ..................... November 4, 2020 ..... May 9, 2017 .............. E–150–2016–0–DE–09 3455206 ..................... (Certificate No. 602017027023.7). 3455206 ..................... November 4, 2020 ..... May 9, 2017 .............. November 4, 2020 .... May 9, 2017 .............. Chemical Conjugates of Evans Blue Derivatives and Their Use as Radiotherapy and Imaging Agents. Chemical Conjugates of Evans Blue Derivatives and Their Use as Radiotherapy and Imaging Agents. Chemical Conjugates of Evans Blue Derivatives and Their Use as Radiotherapy and Imaging Agents. Chemical Conjugates of Evans Blue Derivatives and Their Use as Radiotherapy and Imaging Agents. Chemical Conjugates of Evans Blue Derivatives and Their Use as Radiotherapy and Imaging Agents. Chemical Conjugates of Evans Blue Derivatives and Their Use as Radiotherapy and Imaging Agents. Chemical Conjugates of Evans Blue Derivatives and Their Use as Radiotherapy and Imaging Agents. Chemical Conjugates of Evans Blue Derivatives and Their Use as Radiotherapy and Imaging Agents. Chemical Conjugates of Evans Blue Derivatives and Their Use as Radiotherapy and Imaging Agents. Chemical Conjugates of Evans Blue Derivatives and Their Use as Radiotherapy and Imaging Agents. E–150–2016–0–FR–10 VerDate Sep<11>2014 17:35 Oct 14, 2022 Jkt 259001 PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 E:\FR\FM\17OCN1.SGM 17OCN1

Agencies

[Federal Register Volume 87, Number 199 (Monday, October 17, 2022)]
[Notices]
[Pages 62865-62866]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-22417]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Pain Neurobiology.
    Date: November 8, 2022.
    Time: 11 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Roger Janz, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, (301) 402-8515, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Cancer Immunology and Immunotherapy.
    Date: November 9-10, 2022.
    Time: 8:30 a.m. to 7 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Capitol, 550 C Street SW, Washington, DC 
20024.
    Contact Person: Ola Mae Zack Howard, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4192, MSC 7806, Bethesda, MD 
20892, 301-451-4467, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Small Business: Biomedical Sensing, Measurement and 
Instrumentation.
    Date: November 9-10, 2022.
    Time: 9 a.m. to 7 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Steven Anthony Ripp, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-3010, 
[email protected].

    Name of Committee: Oncology 1--Basic Translational Integrated 
Review Group; Basic Mechanisms of Cancer Health Disparities Study 
Section.
    Date: November 9-10, 2022.
    Time: 9 a.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Sulagna Banerjee, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (612) 309-2479, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Endocrine and Metabolic Systems.
    Date: November 9, 2022.
    Time: 9 a.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Victoria Martinez Virador, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-4703, 
[email protected].

    Name of Committee: Genes, Genomes, and Genetics Integrated 
Review Group; Therapeutic Approaches to Genetic Diseases Study 
Section.
    Date: November 9-10, 2022.
    Time: 9:15 a.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Karobi Moitra, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, (301) 480-6893, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Neurodevelopment, Synaptic Plasticity and 
Neurodegeneration--F03A.
    Date: November 9-10, 2022.
    Time: 9:30 a.m. to 7 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Robert C. Elliott, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5190, MSC 7846, Bethesda, MD 
20892, 301-435-3009, [email protected].

    Name of Committee: Infectious Diseases and Immunology B 
Integrated Review Group; Host Interactions with Bacterial Pathogens 
Study Section.
    Date: November 9-10, 2022.
    Time: 9:30 a.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20876 (Virtual Meeting).
    Contact Person: Michelle Marie Arnold, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 451-7806, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Chemistry, Biochemistry and Biophysics B.
    Date: November 9-10, 2022.
    Time: 9:30 a.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Dennis Pantazatos, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-2381, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Hypersensitivity, Allergies and Mucosal Immunology (HAMI).
    Date: November 9-10, 2022.
    Time: 10 a.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).

[[Page 62866]]

    Contact Person: Kaushiki Mazumdar, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-1427, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Topics in Bacterial Pathogenesis.
    Date: November 9-10, 2022.
    Time: 10 a.m. to 7 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Diana Maria Ortiz-Garcia, Ph.D., Scientific 
Review Officer, The Center for Scientific Review, The National 
Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-
594-5614, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; RFA-NS-22-034: HEAL Initiative.
    Date: November 9, 2022.
    Time: 11 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Roger Janz, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, (301) 402-8515, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Motivated Behavior, Alcohol and 
Neurotoxicology.
    Date: November 9, 2022.
    Time: 11 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Kirk Thompson, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5184, MSC 7844, Bethesda, MD 20892, 301-435-
1242, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: October 7, 2022.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-22417 Filed 10-14-22; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.